A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Czechia- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Czechia390 clinical trials in Brno, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for leukemia, prostate cancer, and gastric cancer.
Studies evaluating novel therapeutic combinations and targeted treatments for various cancer types.
Research focused on treating inflammatory disorders and autoimmune conditions, with particular emphasis on innovative therapies.
Evaluating new biological treatments and their long-term effectiveness in managing chronic conditions.
Studies addressing respiratory diseases and heart conditions, focusing on prevention and treatment strategies.
Testing innovative approaches to improve patient outcomes in respiratory and cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.